{"PubmedArticleSet": {"PubmedArticle": [{"MedlineCitation": {"@Status": "MEDLINE", "@Owner": "NLM", "PMID": {"@Version": "1", "#text": "20819063"}, "DateCompleted": {"Year": "2011", "Month": "04", "Day": "20"}, "DateRevised": {"Year": "2019", "Month": "07", "Day": "28"}, "Article": {"@PubModel": "Print", "Journal": {"ISSN": {"@IssnType": "Electronic", "#text": "1873-4286"}, "JournalIssue": {"@CitedMedium": "Internet", "Volume": "16", "Issue": "29", "PubDate": {"Year": "2010"}}, "Title": "Current pharmaceutical design", "ISOAbbreviation": "Curr. Pharm. Des."}, "ArticleTitle": "Brucella carbonic anhydrases: new targets for designing anti-infective agents.", "Pagination": {"MedlinePgn": "3310-6"}, "Abstract": {"AbstractText": "The facultative intracellular pathogen and zoonotic agent Brucella sp. possesses two carbonic anhydrases (CAs, EC 4.2.1.1), termed bsCA I and bsCA II (in Brucella suis), belonging to the &beta;-class of these metalloproteins. These zinc enzymes, present in many other pathogenic bacteria, have been considered recently as potential antibacterial targets. The catalytic activity of bsCA II is higher than that of bsCA I (for the conversion of CO(2) to bicarbonate). Both enzymes were inhibited by the well-studied inhibitor acetazolamide, a sulfonamide drug. A library of 41 sulfonamides and one sulfamate, among which 12 clinically tested drugs, was used for inhibition studies with bsCA I and II. These compounds were generally much more potent inhibitors of bsCA I (K(Is) of 17-75 nM) than of bsCAII (K(I)s of 84-923nM). However, certain glycosidic sulfonamide derivatives exhibited the same strong inhibitory activity on both bsCA I and bsCA II (K(Is) of 8.9-20 nM). Furthermore, at least one of these glycosylsulfonamides showed a significant inhibition of B. suis growth after 8-11 days of culture in minimal medium. In conclusion, as &beta;-CAs of Brucella are susceptible to inhibition by a wide range of aromatic and heteroaromatic sulfonamides, they may represent novel targets for the development of clinically useful antibacterial agents."}, "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "LastName": "Winum", "ForeName": "Jean-Yves", "Initials": "JY", "AffiliationInfo": {"Affiliation": "Institut des Biomol\u00e9cules Max Mousseron (IBMM), UMR 5247 CNRS-UM1-UM2, B\u00e2timent de Recherche Max Mousseron, EcoleNationale Sup\u00e9rieure de Chimie de Montpellier, 8 rue de l\u2019Ecole Normale, Montpellier Cedex, France. jean-yves.winum@univ-montp2.fr"}}, {"@ValidYN": "Y", "LastName": "K\u00f6hler", "ForeName": "Stephan", "Initials": "S"}, {"@ValidYN": "Y", "LastName": "Supuran", "ForeName": "Claudiu T", "Initials": "CT"}]}, "Language": "eng", "PublicationTypeList": {"PublicationType": [{"@UI": "D016428", "#text": "Journal Article"}, {"@UI": "D013485", "#text": "Research Support, Non-U.S. Gov't"}, {"@UI": "D016454", "#text": "Review"}]}}, "MedlineJournalInfo": {"Country": "United Arab Emirates", "MedlineTA": "Curr Pharm Des", "NlmUniqueID": "9602487", "ISSNLinking": "1381-6128"}, "ChemicalList": {"Chemical": [{"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D000890", "#text": "Anti-Infective Agents"}}, {"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D002257", "#text": "Carbonic Anhydrase Inhibitors"}}, {"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D007527", "#text": "Isoenzymes"}}, {"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D013449", "#text": "Sulfonamides"}}, {"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D013451", "#text": "Sulfonic Acids"}}, {"RegistryNumber": "9NFU33906Q", "NameOfSubstance": {"@UI": "C005741", "#text": "sulfamic acid"}}, {"RegistryNumber": "EC 4.2.1.1", "NameOfSubstance": {"@UI": "D002256", "#text": "Carbonic Anhydrases"}}]}, "CitationSubset": "IM", "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"@UI": "D000595", "@MajorTopicYN": "N", "#text": "Amino Acid Sequence"}}, {"DescriptorName": {"@UI": "D000818", "@MajorTopicYN": "N", "#text": "Animals"}}, {"DescriptorName": {"@UI": "D000890", "@MajorTopicYN": "N", "#text": "Anti-Infective Agents"}, "QualifierName": [{"@UI": "Q000737", "@MajorTopicYN": "N", "#text": "chemistry"}, {"@UI": "Q000494", "@MajorTopicYN": "N", "#text": "pharmacology"}]}, {"DescriptorName": {"@UI": "D002002", "@MajorTopicYN": "N", "#text": "Brucella"}, "QualifierName": [{"@UI": "Q000187", "@MajorTopicYN": "N", "#text": "drug effects"}, {"@UI": "Q000201", "@MajorTopicYN": "Y", "#text": "enzymology"}]}, {"DescriptorName": {"@UI": "D002257", "@MajorTopicYN": "N", "#text": "Carbonic Anhydrase Inhibitors"}, "QualifierName": {"@UI": "Q000494", "@MajorTopicYN": "Y", "#text": "pharmacology"}}, {"DescriptorName": {"@UI": "D002256", "@MajorTopicYN": "N", "#text": "Carbonic Anhydrases"}, "QualifierName": [{"@UI": "Q000737", "@MajorTopicYN": "N", "#text": "chemistry"}, {"@UI": "Q000187", "@MajorTopicYN": "Y", "#text": "drug effects"}]}, {"DescriptorName": {"@UI": "D006801", "@MajorTopicYN": "N", "#text": "Humans"}}, {"DescriptorName": {"@UI": "D007527", "@MajorTopicYN": "N", "#text": "Isoenzymes"}, "QualifierName": [{"@UI": "Q000737", "@MajorTopicYN": "N", "#text": "chemistry"}, {"@UI": "Q000187", "@MajorTopicYN": "Y", "#text": "drug effects"}]}, {"DescriptorName": {"@UI": "D008969", "@MajorTopicYN": "N", "#text": "Molecular Sequence Data"}}, {"DescriptorName": {"@UI": "D015394", "@MajorTopicYN": "N", "#text": "Molecular Structure"}}, {"DescriptorName": {"@UI": "D058990", "@MajorTopicYN": "N", "#text": "Molecular Targeted Therapy"}}, {"DescriptorName": {"@UI": "D013329", "@MajorTopicYN": "N", "#text": "Structure-Activity Relationship"}}, {"DescriptorName": {"@UI": "D013449", "@MajorTopicYN": "N", "#text": "Sulfonamides"}, "QualifierName": [{"@UI": "Q000737", "@MajorTopicYN": "N", "#text": "chemistry"}, {"@UI": "Q000494", "@MajorTopicYN": "N", "#text": "pharmacology"}]}, {"DescriptorName": {"@UI": "D013451", "@MajorTopicYN": "N", "#text": "Sulfonic Acids"}, "QualifierName": [{"@UI": "Q000737", "@MajorTopicYN": "N", "#text": "chemistry"}, {"@UI": "Q000494", "@MajorTopicYN": "N", "#text": "pharmacology"}]}]}}, "PubmedData": {"History": {"PubMedPubDate": [{"@PubStatus": "received", "Year": "2010", "Month": "07", "Day": "05"}, {"@PubStatus": "accepted", "Year": "2010", "Month": "07", "Day": "29"}, {"@PubStatus": "entrez", "Year": "2010", "Month": "9", "Day": "8", "Hour": "6", "Minute": "0"}, {"@PubStatus": "pubmed", "Year": "2010", "Month": "9", "Day": "8", "Hour": "6", "Minute": "0"}, {"@PubStatus": "medline", "Year": "2011", "Month": "4", "Day": "22", "Hour": "6", "Minute": "0"}]}, "PublicationStatus": "ppublish", "ArticleIdList": {"ArticleId": [{"@IdType": "pubmed", "#text": "20819063"}, {"@IdType": "pii", "#text": "BSP/CPD/E-Pub/000223"}, {"@IdType": "doi", "#text": "10.2174/138161210793429850"}]}}}, {"MedlineCitation": {"@Status": "MEDLINE", "@Owner": "NLM", "PMID": {"@Version": "1", "#text": "25238102"}, "DateCompleted": {"Year": "2015", "Month": "08", "Day": "19"}, "DateRevised": {"Year": "2014", "Month": "12", "Day": "02"}, "Article": {"@PubModel": "Print-Electronic", "Journal": {"ISSN": {"@IssnType": "Electronic", "#text": "1872-6968"}, "JournalIssue": {"@CitedMedium": "Internet", "Volume": "126", "PubDate": {"Year": "2014", "Month": "Nov"}}, "Title": "Clinical neurology and neurosurgery", "ISOAbbreviation": "Clin Neurol Neurosurg"}, "ArticleTitle": "Gamma knife radiosurgery of the symptomatic brain stem cavernous angioma with low marginal dose.", "Pagination": {"MedlinePgn": "110-4"}, "ELocationID": [{"@EIdType": "doi", "@ValidYN": "Y", "#text": "10.1016/j.clineuro.2014.08.028"}, {"@EIdType": "pii", "@ValidYN": "Y", "#text": "S0303-8467(14)00338-2"}], "Abstract": {"AbstractText": [{"@Label": "OBJECTIVE", "@NlmCategory": "OBJECTIVE", "#text": "To analyze the outcome of gamma knife radiosurgery (GKS) using low marginal dose for the symptomatic brain stem cavernous angioma (BSCA)."}, {"@Label": "METHODS", "@NlmCategory": "METHODS", "#text": "39 patients (16 males, 23 females) were treated with GKS for BSCA from January 1997 to September 2012. Clinical data were analyzed retrospectively. The mean age was 41.5 years. All patients had a history of symptomatic bleeding once or more before performing GKS. Mean volume of BSCA was 1095.3mm(3) and median prescribed marginal dose was 13 Gy."}, {"@Label": "RESULTS", "@NlmCategory": "RESULTS", "#text": "Mean follow-up period since diagnosis was 4.1 years. The number of hemorrhagic events between initial diagnosis and GKS was 5 over a total of 14.9 patients-years with annual hemorrhagic rate of 33.6%. Following GKS, there were five hemorrhagic events within the first 2 years (8.1%/year) and two after the first 2 years (2.4%/year). The difference was not statistically significant. Neurologic status improved in 24 patients (61.5%), and stationary in eleven (28.2%). 4 patients (10.3%) experienced the exacerbation of symptoms at the last follow-up and none of them were related to the radiation injury. Significant volume reduction after GKS was observed in 24 patients (61.5%). Surgical excision was performed in one patient due to swelling and rebleeding after GKS. Age at presentation, sex, mass size of BSCA, and location, GKS dose did not affect post-GKS hemorrhage."}, {"@Label": "CONCLUSIONS", "@NlmCategory": "CONCLUSIONS", "#text": "GKS for BSCA using relatively low marginal dose is safe and effective. Long-term prospective study is needed to confirm the optimal dose for BSCA."}], "CopyrightInformation": "Copyright \u00a9 2014 Elsevier B.V. All rights reserved."}, "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "LastName": "Kim", "ForeName": "Byung Sup", "Initials": "BS", "AffiliationInfo": {"Affiliation": "Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea."}}, {"@ValidYN": "Y", "LastName": "Yeon", "ForeName": "Je Young", "Initials": "JY", "AffiliationInfo": {"Affiliation": "Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea."}}, {"@ValidYN": "Y", "LastName": "Kim", "ForeName": "Jong-Soo", "Initials": "JS", "AffiliationInfo": {"Affiliation": "Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea."}}, {"@ValidYN": "Y", "LastName": "Hong", "ForeName": "Seung-Chyul", "Initials": "SC", "AffiliationInfo": {"Affiliation": "Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea."}}, {"@ValidYN": "Y", "LastName": "Lee", "ForeName": "Jung-Il", "Initials": "JI", "AffiliationInfo": {"Affiliation": "Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Electronic address: jilee@skku.edu."}}]}, "Language": "eng", "PublicationTypeList": {"PublicationType": {"@UI": "D016428", "#text": "Journal Article"}}, "ArticleDate": {"@DateType": "Electronic", "Year": "2014", "Month": "09", "Day": "06"}}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Clin Neurol Neurosurg", "NlmUniqueID": "7502039", "ISSNLinking": "0303-8467"}, "CitationSubset": "IM", "CommentsCorrectionsList": {"CommentsCorrections": {"@RefType": "CommentIn", "RefSource": "Clin Neurol Neurosurg. 2015 Apr;131:88-9", "PMID": {"@Version": "1", "#text": "25660187"}}}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"@UI": "D000293", "@MajorTopicYN": "N", "#text": "Adolescent"}}, {"DescriptorName": {"@UI": "D000328", "@MajorTopicYN": "N", "#text": "Adult"}}, {"DescriptorName": {"@UI": "D020295", "@MajorTopicYN": "N", "#text": "Brain Stem Neoplasms"}, "QualifierName": {"@UI": "Q000601", "@MajorTopicYN": "Y", "#text": "surgery"}}, {"DescriptorName": {"@UI": "D005260", "@MajorTopicYN": "N", "#text": "Female"}}, {"DescriptorName": {"@UI": "D020786", "@MajorTopicYN": "N", "#text": "Hemangioma, Cavernous, Central Nervous System"}, "QualifierName": {"@UI": "Q000601", "@MajorTopicYN": "Y", "#text": "surgery"}}, {"DescriptorName": {"@UI": "D006801", "@MajorTopicYN": "N", "#text": "Humans"}}, {"DescriptorName": {"@UI": "D008297", "@MajorTopicYN": "N", "#text": "Male"}}, {"DescriptorName": {"@UI": "D008875", "@MajorTopicYN": "N", "#text": "Middle Aged"}}, {"DescriptorName": {"@UI": "D011829", "@MajorTopicYN": "Y", "#text": "Radiation Dosage"}}, {"DescriptorName": {"@UI": "D016634", "@MajorTopicYN": "N", "#text": "Radiosurgery"}, "QualifierName": [{"@UI": "Q000009", "@MajorTopicYN": "N", "#text": "adverse effects"}, {"@UI": "Q000379", "@MajorTopicYN": "Y", "#text": "methods"}, {"@UI": "Q000592", "@MajorTopicYN": "N", "#text": "standards"}]}, {"DescriptorName": {"@UI": "D016896", "@MajorTopicYN": "N", "#text": "Treatment Outcome"}}, {"DescriptorName": {"@UI": "D055815", "@MajorTopicYN": "N", "#text": "Young Adult"}}]}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"@MajorTopicYN": "N", "#text": "Brain stem"}, {"@MajorTopicYN": "N", "#text": "Cavernous angioma"}, {"@MajorTopicYN": "N", "#text": "Gamma knife radiosurgery"}]}}, "PubmedData": {"History": {"PubMedPubDate": [{"@PubStatus": "received", "Year": "2014", "Month": "05", "Day": "28"}, {"@PubStatus": "revised", "Year": "2014", "Month": "08", "Day": "04"}, {"@PubStatus": "accepted", "Year": "2014", "Month": "08", "Day": "25"}, {"@PubStatus": "entrez", "Year": "2014", "Month": "9", "Day": "20", "Hour": "6", "Minute": "0"}, {"@PubStatus": "pubmed", "Year": "2014", "Month": "9", "Day": "23", "Hour": "6", "Minute": "0"}, {"@PubStatus": "medline", "Year": "2015", "Month": "8", "Day": "20", "Hour": "6", "Minute": "0"}]}, "PublicationStatus": "ppublish", "ArticleIdList": {"ArticleId": [{"@IdType": "pubmed", "#text": "25238102"}, {"@IdType": "pii", "#text": "S0303-8467(14)00338-2"}, {"@IdType": "doi", "#text": "10.1016/j.clineuro.2014.08.028"}]}}}, {"MedlineCitation": {"@Status": "MEDLINE", "@Owner": "NLM", "PMID": {"@Version": "1", "#text": "27339283"}, "DateCompleted": {"Year": "2017", "Month": "03", "Day": "09"}, "DateRevised": {"Year": "2017", "Month": "12", "Day": "07"}, "Article": {"@PubModel": "Electronic", "Journal": {"ISSN": {"@IssnType": "Electronic", "#text": "2280-8000"}, "JournalIssue": {"@CitedMedium": "Internet", "Volume": "14 Suppl 1", "PubDate": {"Year": "2016", "Month": "Jul", "Day": "04"}}, "Title": "Journal of applied biomaterials & functional materials", "ISOAbbreviation": "J Appl Biomater Funct Mater"}, "ArticleTitle": "Function investigation of stone mastic asphalt (SMA) mixture partly containing basic oxygen furnace (BOF) slag.", "Pagination": {"MedlinePgn": "e68-72"}, "ELocationID": [{"@EIdType": "doi", "@ValidYN": "Y", "#text": "10.5301/jabfm.5000307"}, {"@EIdType": "pii", "@ValidYN": "Y", "#text": "EF7B1C95-D83D-4A8A-BF3F-6621A1A8ED94"}], "Abstract": {"AbstractText": [{"@Label": "AIMS", "@NlmCategory": "OBJECTIVE", "#text": "In this paper, the effect of the size gradations of basic oxygen furnace (BOF) slag on the functional performances of stone mastic asphalt (SMA) mixture including skid and deformation resistances was investigated."}, {"@Label": "METHODS", "@NlmCategory": "METHODS", "#text": "The industrially produced BOF slag coarse aggregates (BSCA) with size gradations of 4.75-9.5 mm and 9.5-16 mm were used. SMA mixtures were designed according to Marshall procedure. British pendulum number (BPN), indicating the skid resistance of asphalt mixture, was measured by a British pendulum skid resistance device. Flow number (FN) and Marshall quotient (MQ), reflecting the deformation resistance of asphalt mixture, were determined, respectively, based on the results of dynamic creep test and Marshall test (stability and flow value)."}, {"@Label": "RESULTS", "@NlmCategory": "RESULTS", "#text": "Showed that BSCA with a size gradation of 9.5-16 mm performed better in improving the skid and deformation resistance of SMA mixture than BSCA with a size gradation of 4.75-9.5 mm. Furthermore, BSCA with combined size gradations, namely, 4.75-16 mm, worked the best."}, {"@Label": "CONCLUSIONS", "@NlmCategory": "CONCLUSIONS", "#text": "These conclusions would benefit the future extensive utilization of BSCA in asphalt pavement."}]}, "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "LastName": "Chen", "ForeName": "Zongwu", "Initials": "Z", "AffiliationInfo": {"Affiliation": "State Key Laboratory of Silicate Materials for Architectures, Wuhan University of Technology, Wuhan - China."}}, {"@ValidYN": "Y", "LastName": "Wu", "ForeName": "Shaopeng", "Initials": "S", "AffiliationInfo": {"Affiliation": "State Key Laboratory of Silicate Materials for Architectures, Wuhan University of Technology, Wuhan - China."}}, {"@ValidYN": "Y", "LastName": "Pang", "ForeName": "Ling", "Initials": "L", "AffiliationInfo": {"Affiliation": "State Key Laboratory of Silicate Materials for Architectures, Wuhan University of Technology, Wuhan - China."}}, {"@ValidYN": "Y", "LastName": "Xie", "ForeName": "Jun", "Initials": "J", "AffiliationInfo": {"Affiliation": "State Key Laboratory of Silicate Materials for Architectures, Wuhan University of Technology, Wuhan - China."}}]}, "Language": "eng", "PublicationTypeList": {"PublicationType": {"@UI": "D016428", "#text": "Journal Article"}}, "ArticleDate": {"@DateType": "Electronic", "Year": "2016", "Month": "07", "Day": "04"}}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Appl Biomater Funct Mater", "NlmUniqueID": "101586617", "ISSNLinking": "2280-8000"}, "ChemicalList": {"Chemical": [{"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D006838", "#text": "Hydrocarbons"}}, {"RegistryNumber": "8052-42-4", "NameOfSubstance": {"@UI": "C006647", "#text": "asphalt"}}]}, "CitationSubset": "IM", "MeshHeadingList": {"MeshHeading": {"DescriptorName": {"@UI": "D006838", "@MajorTopicYN": "N", "#text": "Hydrocarbons"}, "QualifierName": {"@UI": "Q000737", "@MajorTopicYN": "Y", "#text": "chemistry"}}}}, "PubmedData": {"History": {"PubMedPubDate": [{"@PubStatus": "accepted", "Year": "2016", "Month": "05", "Day": "09"}, {"@PubStatus": "entrez", "Year": "2016", "Month": "6", "Day": "25", "Hour": "6", "Minute": "0"}, {"@PubStatus": "pubmed", "Year": "2016", "Month": "6", "Day": "25", "Hour": "6", "Minute": "0"}, {"@PubStatus": "medline", "Year": "2017", "Month": "3", "Day": "10", "Hour": "6", "Minute": "0"}]}, "PublicationStatus": "epublish", "ArticleIdList": {"ArticleId": [{"@IdType": "pubmed", "#text": "27339283"}, {"@IdType": "pii", "#text": "EF7B1C95-D83D-4A8A-BF3F-6621A1A8ED94"}, {"@IdType": "doi", "#text": "10.5301/jabfm.5000307"}]}}}, {"MedlineCitation": {"@Status": "MEDLINE", "@Owner": "NLM", "PMID": {"@Version": "1", "#text": "27311428"}, "DateCompleted": {"Year": "2017", "Month": "03", "Day": "09"}, "DateRevised": {"Year": "2017", "Month": "12", "Day": "07"}, "Article": {"@PubModel": "Electronic", "Journal": {"ISSN": {"@IssnType": "Electronic", "#text": "2280-8000"}, "JournalIssue": {"@CitedMedium": "Internet", "Volume": "14 Suppl 1", "PubDate": {"Year": "2016", "Month": "Jul", "Day": "04"}}, "Title": "Journal of applied biomaterials & functional materials", "ISOAbbreviation": "J Appl Biomater Funct Mater"}, "ArticleTitle": "Function evaluation of asphalt mixture with industrially produced BOF slag aggregate.", "Pagination": {"MedlinePgn": "e7-e10"}, "ELocationID": [{"@EIdType": "doi", "@ValidYN": "Y", "#text": "10.5301/jabfm.5000297"}, {"@EIdType": "pii", "@ValidYN": "Y", "#text": "8D0CAD68-5828-47E1-98BB-9E5F29BA8DF7"}], "Abstract": {"AbstractText": [{"@Label": "BACKGROUND", "@NlmCategory": "BACKGROUND", "#text": "Laboratory research suggested that basic oxygen furnace (BOF) slag-based asphalt mixture was a functional material. However, the BOF slag aggregate's quality was difficult to control when it was heavily used in entity engineering."}, {"@Label": "AIMS", "@NlmCategory": "OBJECTIVE", "#text": "The primary objective of this research was to evaluate the functional performances of asphalt mixture containing BOF slag coarse aggregate (BSCA), which was from an industrialized production line."}, {"@Label": "METHODS", "@NlmCategory": "METHODS", "#text": "Limestone mixture was a control group. The Marshall method was first adopted to design asphalt mixtures. The performances of limestone asphalt mixture and BOF slag asphalt mixture including fatigue failure resistance and moisture stability were then evaluated and compared."}, {"@Label": "RESULTS", "@NlmCategory": "RESULTS", "#text": "Results showed that the asphalt mixture containing BSCA possessed better durability, which meant the quality of BSCA from industrialized production lines was well controlled and this BSCA can be heavily used in entity engineering."}]}, "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "LastName": "Zhao", "ForeName": "Meiling", "Initials": "M", "AffiliationInfo": {"Affiliation": "State Key Laboratory of Silicate Materials for Architectures, Wuhan University of Technology, Wuhan - China."}}, {"@ValidYN": "Y", "LastName": "Wu", "ForeName": "Shaopeng", "Initials": "S", "AffiliationInfo": {"Affiliation": "State Key Laboratory of Silicate Materials for Architectures, Wuhan University of Technology, Wuhan - China."}}, {"@ValidYN": "Y", "LastName": "Chen", "ForeName": "Zongwu", "Initials": "Z", "AffiliationInfo": {"Affiliation": "State Key Laboratory of Silicate Materials for Architectures, Wuhan University of Technology, Wuhan - China."}}, {"@ValidYN": "Y", "LastName": "Li", "ForeName": "Chao", "Initials": "C", "AffiliationInfo": {"Affiliation": "State Key Laboratory of Silicate Materials for Architectures, Wuhan University of Technology, Wuhan - China."}}]}, "Language": "eng", "PublicationTypeList": {"PublicationType": {"@UI": "D016428", "#text": "Journal Article"}}, "ArticleDate": {"@DateType": "Electronic", "Year": "2016", "Month": "07", "Day": "04"}}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Appl Biomater Funct Mater", "NlmUniqueID": "101586617", "ISSNLinking": "2280-8000"}, "ChemicalList": {"Chemical": [{"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D006838", "#text": "Hydrocarbons"}}, {"RegistryNumber": "8052-42-4", "NameOfSubstance": {"@UI": "C006647", "#text": "asphalt"}}, {"RegistryNumber": "H0G9379FGK", "NameOfSubstance": {"@UI": "D002119", "#text": "Calcium Carbonate"}}]}, "CitationSubset": "IM", "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"@UI": "D002119", "@MajorTopicYN": "N", "#text": "Calcium Carbonate"}, "QualifierName": {"@UI": "Q000737", "@MajorTopicYN": "Y", "#text": "chemistry"}}, {"DescriptorName": {"@UI": "D006838", "@MajorTopicYN": "N", "#text": "Hydrocarbons"}, "QualifierName": {"@UI": "Q000737", "@MajorTopicYN": "Y", "#text": "chemistry"}}, {"DescriptorName": {"@UI": "D008422", "@MajorTopicYN": "Y", "#text": "Materials Testing"}}, {"DescriptorName": {"@UI": "D013314", "@MajorTopicYN": "N", "#text": "Stress, Mechanical"}}]}}, "PubmedData": {"History": {"PubMedPubDate": [{"@PubStatus": "accepted", "Year": "2016", "Month": "04", "Day": "14"}, {"@PubStatus": "entrez", "Year": "2016", "Month": "6", "Day": "18", "Hour": "6", "Minute": "0"}, {"@PubStatus": "pubmed", "Year": "2016", "Month": "6", "Day": "18", "Hour": "6", "Minute": "0"}, {"@PubStatus": "medline", "Year": "2017", "Month": "3", "Day": "10", "Hour": "6", "Minute": "0"}]}, "PublicationStatus": "epublish", "ArticleIdList": {"ArticleId": [{"@IdType": "pubmed", "#text": "27311428"}, {"@IdType": "pii", "#text": "8D0CAD68-5828-47E1-98BB-9E5F29BA8DF7"}, {"@IdType": "doi", "#text": "10.5301/jabfm.5000297"}]}}}, {"MedlineCitation": {"@Status": "MEDLINE", "@Owner": "NLM", "PMID": {"@Version": "1", "#text": "21251841"}, "DateCompleted": {"Year": "2011", "Month": "08", "Day": "23"}, "DateRevised": {"Year": "2012", "Month": "11", "Day": "15"}, "Article": {"@PubModel": "Print-Electronic", "Journal": {"ISSN": {"@IssnType": "Electronic", "#text": "1464-3391"}, "JournalIssue": {"@CitedMedium": "Internet", "Volume": "19", "Issue": "3", "PubDate": {"Year": "2011", "Month": "Feb", "Day": "01"}}, "Title": "Bioorganic & medicinal chemistry", "ISOAbbreviation": "Bioorg. Med. Chem."}, "ArticleTitle": "A new \u03b2-carbonic anhydrase from Brucella suis, its cloning, characterization, and inhibition with sulfonamides and sulfamates, leading to impaired pathogen growth.", "Pagination": {"MedlinePgn": "1172-8"}, "ELocationID": {"@EIdType": "doi", "@ValidYN": "Y", "#text": "10.1016/j.bmc.2010.12.048"}, "Abstract": {"AbstractText": "A \u03b2-carbonic anhydrase (CA, EC 4.2.1.1) from the bacterial pathogen Brucella suis, bsCA II, has been cloned, purified, and characterized kinetically. bsCA II showed high catalytic activity for the hydration of CO(2) to bicarbonate, with a k(cat) of 1.1\u00d710(6), and k(cat)/K(m) of 8.9\u00d710(7)M(-1)s(-1). A panel of sulfonamides and sulfamates have been investigated for inhibition of this enzyme. All types of activities, from the low nanomolar to the micromolar, have been detected for these derivatives, which showed inhibition constants in the range of 7.3nM-8.56\u03bcM. The best bsCA II inhibitors were some glycosylated sulfanilamides, aliphatic sulfamates, and halogenated sulfanilamides, with inhibition constants of 7.3-87nM. Some of these dual inhibitors of bsCA I and II, also inhibited bacterial growth in vitro, in liquid cultures. These promising data on live bacteria allow us to propose bacterial \u03b2-CA inhibition as an approach for obtaining anti-infective agents with a new mechanism of action compared to classical antibiotics.", "CopyrightInformation": "Copyright \u00a9 2011 Elsevier Ltd. All rights reserved."}, "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "LastName": "Joseph", "ForeName": "Pascale", "Initials": "P", "AffiliationInfo": {"Affiliation": "Centre d'Etudes d'Agents Pathog\u00e8nes et Biotechnologies pour la Sant\u00e9 (CPBS), UMR 5236 CNRS-UM1-UM2, Universit\u00e9 Montpellier II, cc100, Place E. Bataillon, 34095 Montpellier, France."}}, {"@ValidYN": "Y", "LastName": "Ouahrani-Bettache", "ForeName": "Safia", "Initials": "S"}, {"@ValidYN": "Y", "LastName": "Montero", "ForeName": "Jean-Louis", "Initials": "JL"}, {"@ValidYN": "Y", "LastName": "Nishimori", "ForeName": "Isao", "Initials": "I"}, {"@ValidYN": "Y", "LastName": "Minakuchi", "ForeName": "Tomoko", "Initials": "T"}, {"@ValidYN": "Y", "LastName": "Vullo", "ForeName": "Daniela", "Initials": "D"}, {"@ValidYN": "Y", "LastName": "Scozzafava", "ForeName": "Andrea", "Initials": "A"}, {"@ValidYN": "Y", "LastName": "Winum", "ForeName": "Jean-Yves", "Initials": "JY"}, {"@ValidYN": "Y", "LastName": "K\u00f6hler", "ForeName": "Stephan", "Initials": "S"}, {"@ValidYN": "Y", "LastName": "Supuran", "ForeName": "Claudiu T", "Initials": "CT"}]}, "Language": "eng", "PublicationTypeList": {"PublicationType": [{"@UI": "D016428", "#text": "Journal Article"}, {"@UI": "D013485", "#text": "Research Support, Non-U.S. Gov't"}]}, "ArticleDate": {"@DateType": "Electronic", "Year": "2010", "Month": "12", "Day": "30"}}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Bioorg Med Chem", "NlmUniqueID": "9413298", "ISSNLinking": "0968-0896"}, "ChemicalList": {"Chemical": [{"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D000900", "#text": "Anti-Bacterial Agents"}}, {"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D002257", "#text": "Carbonic Anhydrase Inhibitors"}}, {"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D013449", "#text": "Sulfonamides"}}, {"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D013451", "#text": "Sulfonic Acids"}}, {"RegistryNumber": "9NFU33906Q", "NameOfSubstance": {"@UI": "C005741", "#text": "sulfamic acid"}}, {"RegistryNumber": "EC 4.2.1.1", "NameOfSubstance": {"@UI": "D002256", "#text": "Carbonic Anhydrases"}}]}, "CitationSubset": "IM", "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"@UI": "D000900", "@MajorTopicYN": "N", "#text": "Anti-Bacterial Agents"}, "QualifierName": [{"@UI": "Q000737", "@MajorTopicYN": "N", "#text": "chemistry"}, {"@UI": "Q000494", "@MajorTopicYN": "Y", "#text": "pharmacology"}]}, {"DescriptorName": {"@UI": "D041021", "@MajorTopicYN": "N", "#text": "Brucella suis"}, "QualifierName": [{"@UI": "Q000187", "@MajorTopicYN": "Y", "#text": "drug effects"}, {"@UI": "Q000201", "@MajorTopicYN": "N", "#text": "enzymology"}, {"@UI": "Q000254", "@MajorTopicYN": "N", "#text": "growth & development"}]}, {"DescriptorName": {"@UI": "D002257", "@MajorTopicYN": "N", "#text": "Carbonic Anhydrase Inhibitors"}, "QualifierName": [{"@UI": "Q000737", "@MajorTopicYN": "N", "#text": "chemistry"}, {"@UI": "Q000494", "@MajorTopicYN": "Y", "#text": "pharmacology"}]}, {"DescriptorName": {"@UI": "D002256", "@MajorTopicYN": "N", "#text": "Carbonic Anhydrases"}, "QualifierName": [{"@UI": "Q000737", "@MajorTopicYN": "N", "#text": "chemistry"}, {"@UI": "Q000235", "@MajorTopicYN": "N", "#text": "genetics"}, {"@UI": "Q000302", "@MajorTopicYN": "N", "#text": "isolation & purification"}, {"@UI": "Q000378", "@MajorTopicYN": "Y", "#text": "metabolism"}]}, {"DescriptorName": {"@UI": "D003001", "@MajorTopicYN": "N", "#text": "Cloning, Molecular"}}, {"DescriptorName": {"@UI": "D015195", "@MajorTopicYN": "N", "#text": "Drug Design"}}, {"DescriptorName": {"@UI": "D055808", "@MajorTopicYN": "N", "#text": "Drug Discovery"}}, {"DescriptorName": {"@UI": "D020128", "@MajorTopicYN": "N", "#text": "Inhibitory Concentration 50"}}, {"DescriptorName": {"@UI": "D007700", "@MajorTopicYN": "N", "#text": "Kinetics"}}, {"DescriptorName": {"@UI": "D013449", "@MajorTopicYN": "N", "#text": "Sulfonamides"}, "QualifierName": [{"@UI": "Q000737", "@MajorTopicYN": "N", "#text": "chemistry"}, {"@UI": "Q000494", "@MajorTopicYN": "Y", "#text": "pharmacology"}]}, {"DescriptorName": {"@UI": "D013451", "@MajorTopicYN": "N", "#text": "Sulfonic Acids"}, "QualifierName": [{"@UI": "Q000737", "@MajorTopicYN": "N", "#text": "chemistry"}, {"@UI": "Q000494", "@MajorTopicYN": "Y", "#text": "pharmacology"}]}]}}, "PubmedData": {"History": {"PubMedPubDate": [{"@PubStatus": "received", "Year": "2010", "Month": "09", "Day": "02"}, {"@PubStatus": "revised", "Year": "2010", "Month": "12", "Day": "22"}, {"@PubStatus": "accepted", "Year": "2010", "Month": "12", "Day": "23"}, {"@PubStatus": "entrez", "Year": "2011", "Month": "1", "Day": "22", "Hour": "6", "Minute": "0"}, {"@PubStatus": "pubmed", "Year": "2011", "Month": "1", "Day": "22", "Hour": "6", "Minute": "0"}, {"@PubStatus": "medline", "Year": "2011", "Month": "8", "Day": "24", "Hour": "6", "Minute": "0"}]}, "PublicationStatus": "ppublish", "ArticleIdList": {"ArticleId": [{"@IdType": "pubmed", "#text": "21251841"}, {"@IdType": "pii", "#text": "S0968-0896(10)01150-8"}, {"@IdType": "doi", "#text": "10.1016/j.bmc.2010.12.048"}]}}}, {"MedlineCitation": {"@Status": "MEDLINE", "@Owner": "NLM", "PMID": {"@Version": "1", "#text": "25792504"}, "DateCompleted": {"Year": "2016", "Month": "06", "Day": "07"}, "DateRevised": {"Year": "2015", "Month": "10", "Day": "30"}, "Article": {"@PubModel": "Print-Electronic", "Journal": {"ISSN": {"@IssnType": "Electronic", "#text": "1475-6374"}, "JournalIssue": {"@CitedMedium": "Internet", "Volume": "30", "Issue": "6", "PubDate": {"Year": "2015", "Month": "Dec"}}, "Title": "Journal of enzyme inhibition and medicinal chemistry", "ISOAbbreviation": "J Enzyme Inhib Med Chem"}, "ArticleTitle": "N-glycosyl-N-hydroxysulfamides as potent inhibitors of Brucella suis carbonic anhydrases.", "Pagination": {"MedlinePgn": "1010-2"}, "ELocationID": {"@EIdType": "doi", "@ValidYN": "Y", "#text": "10.3109/14756366.2014.986119"}, "Abstract": {"AbstractText": "We investigated a series of N-hydroxysulfamides obtained by Ferrier sulfamidoglycosylation for the inhibition of two bacterial carbonic anhydrases (CAs, EC 4.2.1.1) present in the pathogen Brucella suis. bsCA I was moderately inhibited by these compounds with inhibition constants ranging between 522 and 958 nM and no notable differences of activity between the acetylated or the corresponding deacetylated derivatives. The compounds incorporating two trans-acetates and the corresponding deprotected ones were the most effective inhibitors in the series. bsCA II was better inhibited, with inhibition constants ranging between 59.8 and 799 nM. The acetylated derivatives were generally better bsCA II inhibitors compared to the corresponding deacetylated compounds. Although these compounds were not highly isoform-selective CA inhibitors (CAIs) for the bacterial over the human CA isoforms, some of them possess inhibition profiles that make them interesting leads for obtaining better and more isoform-selective CAIs targeting bacterial enzymes."}, "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "LastName": "Ombouma", "ForeName": "Joanna", "Initials": "J", "AffiliationInfo": {"Affiliation": "a Institut des Biomol\u00e9cules Max Mousseron (IBMM) UMR 5247 CNRS-ENSCM-UM1-UM2, B\u00e2timent de Recherche Max Mousseron, Ecole Nationale Sup\u00e9rieure de Chimie de Montpellier , Montpellier Cedex , France ."}}, {"@ValidYN": "Y", "LastName": "Vullo", "ForeName": "Daniela", "Initials": "D", "AffiliationInfo": {"Affiliation": "b Laboratorio di Chimica Bioinorganica , Polo Scientifico, Universit\u00e0 degli Studi di Firenze , Sesto Fiorentino, Florence , Italy ."}}, {"@ValidYN": "Y", "LastName": "K\u00f6hler", "ForeName": "Stephan", "Initials": "S", "AffiliationInfo": {"Affiliation": "c Centre d'\u00c9tudes d'Agents Pathog\u00e8nes et Biotechnologies pour la Sant\u00e9 (CPBS), UMR5236, CNRS-Universit\u00e9 Montpellier I-Universit\u00e9 Montpellier II , Montpellier Cedex , France , and."}}, {"@ValidYN": "Y", "LastName": "Dumy", "ForeName": "Pascal", "Initials": "P", "AffiliationInfo": {"Affiliation": "a Institut des Biomol\u00e9cules Max Mousseron (IBMM) UMR 5247 CNRS-ENSCM-UM1-UM2, B\u00e2timent de Recherche Max Mousseron, Ecole Nationale Sup\u00e9rieure de Chimie de Montpellier , Montpellier Cedex , France ."}}, {"@ValidYN": "Y", "LastName": "Supuran", "ForeName": "Claudiu T", "Initials": "CT", "AffiliationInfo": {"Affiliation": "d Neurofarba Department , Section of Pharmaceutical and Nutriceutical Sciences, Universit\u00e0 degli Studi di Firenze , Via Ugo Schiff, Florence , Italy."}}, {"@ValidYN": "Y", "LastName": "Winum", "ForeName": "Jean-Yves", "Initials": "JY", "AffiliationInfo": {"Affiliation": "a Institut des Biomol\u00e9cules Max Mousseron (IBMM) UMR 5247 CNRS-ENSCM-UM1-UM2, B\u00e2timent de Recherche Max Mousseron, Ecole Nationale Sup\u00e9rieure de Chimie de Montpellier , Montpellier Cedex , France ."}}]}, "Language": "eng", "PublicationTypeList": {"PublicationType": [{"@UI": "D016428", "#text": "Journal Article"}, {"@UI": "D013485", "#text": "Research Support, Non-U.S. Gov't"}]}, "ArticleDate": {"@DateType": "Electronic", "Year": "2015", "Month": "03", "Day": "20"}}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Enzyme Inhib Med Chem", "NlmUniqueID": "101150203", "ISSNLinking": "1475-6366"}, "ChemicalList": {"Chemical": [{"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D000617", "#text": "Aminoglycosides"}}, {"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D002257", "#text": "Carbonic Anhydrase Inhibitors"}}, {"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D013449", "#text": "Sulfonamides"}}, {"RegistryNumber": "EC 4.2.1.-", "NameOfSubstance": {"@UI": "D024401", "#text": "Carbonic Anhydrase I"}}, {"RegistryNumber": "EC 4.2.1.-", "NameOfSubstance": {"@UI": "D024402", "#text": "Carbonic Anhydrase II"}}]}, "CitationSubset": "IM", "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"@UI": "D000617", "@MajorTopicYN": "N", "#text": "Aminoglycosides"}, "QualifierName": [{"@UI": "Q000138", "@MajorTopicYN": "N", "#text": "chemical synthesis"}, {"@UI": "Q000737", "@MajorTopicYN": "N", "#text": "chemistry"}, {"@UI": "Q000494", "@MajorTopicYN": "Y", "#text": "pharmacology"}]}, {"DescriptorName": {"@UI": "D041021", "@MajorTopicYN": "N", "#text": "Brucella suis"}, "QualifierName": {"@UI": "Q000201", "@MajorTopicYN": "Y", "#text": "enzymology"}}, {"DescriptorName": {"@UI": "D024401", "@MajorTopicYN": "N", "#text": "Carbonic Anhydrase I"}, "QualifierName": [{"@UI": "Q000037", "@MajorTopicYN": "Y", "#text": "antagonists & inhibitors"}, {"@UI": "Q000378", "@MajorTopicYN": "N", "#text": "metabolism"}]}, {"DescriptorName": {"@UI": "D024402", "@MajorTopicYN": "N", "#text": "Carbonic Anhydrase II"}, "QualifierName": [{"@UI": "Q000037", "@MajorTopicYN": "Y", "#text": "antagonists & inhibitors"}, {"@UI": "Q000378", "@MajorTopicYN": "N", "#text": "metabolism"}]}, {"DescriptorName": {"@UI": "D002257", "@MajorTopicYN": "N", "#text": "Carbonic Anhydrase Inhibitors"}, "QualifierName": [{"@UI": "Q000138", "@MajorTopicYN": "N", "#text": "chemical synthesis"}, {"@UI": "Q000737", "@MajorTopicYN": "N", "#text": "chemistry"}, {"@UI": "Q000494", "@MajorTopicYN": "Y", "#text": "pharmacology"}]}, {"DescriptorName": {"@UI": "D004305", "@MajorTopicYN": "N", "#text": "Dose-Response Relationship, Drug"}}, {"DescriptorName": {"@UI": "D006801", "@MajorTopicYN": "N", "#text": "Humans"}}, {"DescriptorName": {"@UI": "D015394", "@MajorTopicYN": "N", "#text": "Molecular Structure"}}, {"DescriptorName": {"@UI": "D013329", "@MajorTopicYN": "N", "#text": "Structure-Activity Relationship"}}, {"DescriptorName": {"@UI": "D013449", "@MajorTopicYN": "N", "#text": "Sulfonamides"}, "QualifierName": [{"@UI": "Q000138", "@MajorTopicYN": "N", "#text": "chemical synthesis"}, {"@UI": "Q000737", "@MajorTopicYN": "N", "#text": "chemistry"}, {"@UI": "Q000494", "@MajorTopicYN": "Y", "#text": "pharmacology"}]}]}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"@MajorTopicYN": "N", "#text": "Brucella suis"}, {"@MajorTopicYN": "N", "#text": "N-hydroxysulfamide"}, {"@MajorTopicYN": "N", "#text": "carbonic anhydrase"}, {"@MajorTopicYN": "N", "#text": "glycoinhibitor"}, {"@MajorTopicYN": "N", "#text": "glycosyl derivative"}]}}, "PubmedData": {"History": {"PubMedPubDate": [{"@PubStatus": "entrez", "Year": "2015", "Month": "3", "Day": "21", "Hour": "6", "Minute": "0"}, {"@PubStatus": "pubmed", "Year": "2015", "Month": "3", "Day": "21", "Hour": "6", "Minute": "0"}, {"@PubStatus": "medline", "Year": "2016", "Month": "6", "Day": "9", "Hour": "6", "Minute": "0"}]}, "PublicationStatus": "ppublish", "ArticleIdList": {"ArticleId": [{"@IdType": "pubmed", "#text": "25792504"}, {"@IdType": "doi", "#text": "10.3109/14756366.2014.986119"}]}}}, {"MedlineCitation": {"@Status": "MEDLINE", "@Owner": "NLM", "PMID": {"@Version": "1", "#text": "20158185"}, "DateCompleted": {"Year": "2010", "Month": "04", "Day": "01"}, "DateRevised": {"Year": "2010", "Month": "03", "Day": "04"}, "Article": {"@PubModel": "Print", "Journal": {"ISSN": {"@IssnType": "Electronic", "#text": "1520-4804"}, "JournalIssue": {"@CitedMedium": "Internet", "Volume": "53", "Issue": "5", "PubDate": {"Year": "2010", "Month": "Mar", "Day": "11"}}, "Title": "Journal of medicinal chemistry", "ISOAbbreviation": "J. Med. Chem."}, "ArticleTitle": "Cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Brucella suis.", "Pagination": {"MedlinePgn": "2277-85"}, "ELocationID": {"@EIdType": "doi", "@ValidYN": "Y", "#text": "10.1021/jm901855h"}, "Abstract": {"AbstractText": "A beta-carbonic anhydrase (CA, EC 4.2.1.1) from the bacterial pathogen Brucella suis, bsCA 1, has been cloned, purified, and characterized kinetically. bsCA 1 has appreciable activity as catalyst for the hydration of CO(2) to bicarbonate, with a k(cat) of 6.4 x 10(5) s(-1) and k(cat)/K(m) of 3.9 x 10(7) M(-1).s(-1). A panel of 38 sulfonamides and one sulfamate have been investigated for inhibition of this new beta-CA. All types of activities have been detected, with K(I)s in the range of 17 nM to 5.87 microM. The best bsCA 1 inhibitors were ethoxzolamide (17 nM), celecoxib (18 nM), dorzolamide (21 nM), valdecoxib, and sulpiride (19 nM). Whether bsCA 1 inhibitors may have application in the fight against brucellosis, an endemic disease and the major bacterial zoonosis, producing debilitating infection in humans and animals, warrants further studies."}, "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "LastName": "Joseph", "ForeName": "Pascale", "Initials": "P", "AffiliationInfo": {"Affiliation": "Centre d'Etudes d'Agents Pathogenes et Biotechnologies pour la Sante, UMR 5236 CNRS-UM1-UM2, Universite Montpellier II, cc100, Place E Bataillon, 34095 Montpellier, France."}}, {"@ValidYN": "Y", "LastName": "Turtaut", "ForeName": "Fran\u00e7ois", "Initials": "F"}, {"@ValidYN": "Y", "LastName": "Ouahrani-Bettache", "ForeName": "Safia", "Initials": "S"}, {"@ValidYN": "Y", "LastName": "Montero", "ForeName": "Jean-Louis", "Initials": "JL"}, {"@ValidYN": "Y", "LastName": "Nishimori", "ForeName": "Isao", "Initials": "I"}, {"@ValidYN": "Y", "LastName": "Minakuchi", "ForeName": "Tomoko", "Initials": "T"}, {"@ValidYN": "Y", "LastName": "Vullo", "ForeName": "Daniela", "Initials": "D"}, {"@ValidYN": "Y", "LastName": "Scozzafava", "ForeName": "Andrea", "Initials": "A"}, {"@ValidYN": "Y", "LastName": "K\u00f6hler", "ForeName": "Stephan", "Initials": "S"}, {"@ValidYN": "Y", "LastName": "Winum", "ForeName": "Jean-Yves", "Initials": "JY"}, {"@ValidYN": "Y", "LastName": "Supuran", "ForeName": "Claudiu T", "Initials": "CT"}]}, "Language": "eng", "DataBankList": {"@CompleteYN": "Y", "DataBank": {"DataBankName": "RefSeq", "AccessionNumberList": {"AccessionNumber": "NC_004311"}}}, "PublicationTypeList": {"PublicationType": [{"@UI": "D016428", "#text": "Journal Article"}, {"@UI": "D013485", "#text": "Research Support, Non-U.S. Gov't"}]}}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Med Chem", "NlmUniqueID": "9716531", "ISSNLinking": "0022-2623"}, "ChemicalList": {"Chemical": [{"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D004269", "#text": "DNA, Bacterial"}}, {"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D013449", "#text": "Sulfonamides"}}, {"RegistryNumber": "EC 4.2.1.1", "NameOfSubstance": {"@UI": "D002256", "#text": "Carbonic Anhydrases"}}]}, "CitationSubset": "IM", "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"@UI": "D000595", "@MajorTopicYN": "N", "#text": "Amino Acid Sequence"}}, {"DescriptorName": {"@UI": "D000818", "@MajorTopicYN": "N", "#text": "Animals"}}, {"DescriptorName": {"@UI": "D001483", "@MajorTopicYN": "N", "#text": "Base Sequence"}}, {"DescriptorName": {"@UI": "D041021", "@MajorTopicYN": "N", "#text": "Brucella suis"}, "QualifierName": [{"@UI": "Q000201", "@MajorTopicYN": "Y", "#text": "enzymology"}, {"@UI": "Q000235", "@MajorTopicYN": "N", "#text": "genetics"}]}, {"DescriptorName": {"@UI": "D002006", "@MajorTopicYN": "N", "#text": "Brucellosis"}, "QualifierName": {"@UI": "Q000188", "@MajorTopicYN": "Y", "#text": "drug therapy"}}, {"DescriptorName": {"@UI": "D002256", "@MajorTopicYN": "N", "#text": "Carbonic Anhydrases"}, "QualifierName": [{"@UI": "Q000187", "@MajorTopicYN": "N", "#text": "drug effects"}, {"@UI": "Q000235", "@MajorTopicYN": "Y", "#text": "genetics"}]}, {"DescriptorName": {"@UI": "D003001", "@MajorTopicYN": "N", "#text": "Cloning, Molecular"}}, {"DescriptorName": {"@UI": "D004269", "@MajorTopicYN": "N", "#text": "DNA, Bacterial"}, "QualifierName": [{"@UI": "Q000737", "@MajorTopicYN": "N", "#text": "chemistry"}, {"@UI": "Q000235", "@MajorTopicYN": "N", "#text": "genetics"}]}, {"DescriptorName": {"@UI": "D006801", "@MajorTopicYN": "N", "#text": "Humans"}}, {"DescriptorName": {"@UI": "D007700", "@MajorTopicYN": "N", "#text": "Kinetics"}}, {"DescriptorName": {"@UI": "D008969", "@MajorTopicYN": "N", "#text": "Molecular Sequence Data"}}, {"DescriptorName": {"@UI": "D010802", "@MajorTopicYN": "Y", "#text": "Phylogeny"}}, {"DescriptorName": {"@UI": "D016133", "@MajorTopicYN": "N", "#text": "Polymerase Chain Reaction"}}, {"DescriptorName": {"@UI": "D016415", "@MajorTopicYN": "N", "#text": "Sequence Alignment"}}, {"DescriptorName": {"@UI": "D017422", "@MajorTopicYN": "N", "#text": "Sequence Analysis, DNA"}}, {"DescriptorName": {"@UI": "D013329", "@MajorTopicYN": "N", "#text": "Structure-Activity Relationship"}}, {"DescriptorName": {"@UI": "D013449", "@MajorTopicYN": "N", "#text": "Sulfonamides"}, "QualifierName": {"@UI": "Q000494", "@MajorTopicYN": "Y", "#text": "pharmacology"}}]}}, "PubmedData": {"History": {"PubMedPubDate": [{"@PubStatus": "entrez", "Year": "2010", "Month": "2", "Day": "18", "Hour": "6", "Minute": "0"}, {"@PubStatus": "pubmed", "Year": "2010", "Month": "2", "Day": "18", "Hour": "6", "Minute": "0"}, {"@PubStatus": "medline", "Year": "2010", "Month": "4", "Day": "2", "Hour": "6", "Minute": "0"}]}, "PublicationStatus": "ppublish", "ArticleIdList": {"ArticleId": [{"@IdType": "pubmed", "#text": "20158185"}, {"@IdType": "doi", "#text": "10.1021/jm901855h"}]}}}, {"MedlineCitation": {"@Status": "MEDLINE", "@Owner": "NLM", "PMID": {"@Version": "1", "#text": "28274160"}, "DateCompleted": {"Year": "2017", "Month": "03", "Day": "17"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"@PubModel": "Print", "Journal": {"ISSN": {"@IssnType": "Electronic", "#text": "1475-6374"}, "JournalIssue": {"@CitedMedium": "Internet", "Volume": "32", "Issue": "1", "PubDate": {"Year": "2017", "Month": "Dec"}}, "Title": "Journal of enzyme inhibition and medicinal chemistry", "ISOAbbreviation": "J Enzyme Inhib Med Chem"}, "ArticleTitle": "Brucella suis carbonic anhydrases and their inhibitors: Towards alternative antibiotics?", "Pagination": {"MedlinePgn": "683-687"}, "ELocationID": {"@EIdType": "doi", "@ValidYN": "Y", "#text": "10.1080/14756366.2017.1295451"}, "Abstract": {"AbstractText": "Carbonic anhydrases have started to emerge as new potential antibacterial targets for several pathogens. Two \u03b2-carbonic anhydrases, denominated bsCA I and bsCA II, have been isolated and characterized from the bacterial pathogen Brucella suis, the causative agent of brucellosis or Malta fever. These enzymes have been investigated in detail and a wide range of classical aromatic and heteroaromatic sulfonamides as well as carbohydrate-based compounds have been found to inhibit selectively and efficiently Brucella suis carbonic anhydrases. Inhibition of these metalloenzymes constitutes a novel approach for the potential development of new anti-Brucella agents. This review aims at discussing the recent literature on this topic."}, "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "LastName": "K\u00f6hler", "ForeName": "Stephan", "Initials": "S", "AffiliationInfo": {"Affiliation": "a Institut de Recherche en Infectiologie de Montpellier (IRIM) UMR 9004, Universit\u00e9 de Montpellier, CNRS , Montpellier , France."}}, {"@ValidYN": "Y", "LastName": "Ouahrani-Bettache", "ForeName": "Safia", "Initials": "S", "AffiliationInfo": {"Affiliation": "a Institut de Recherche en Infectiologie de Montpellier (IRIM) UMR 9004, Universit\u00e9 de Montpellier, CNRS , Montpellier , France."}}, {"@ValidYN": "Y", "LastName": "Winum", "ForeName": "Jean-Yves", "Initials": "JY", "AffiliationInfo": {"Affiliation": "b Institut des Biomol\u00e9cules Max Mousseron (IBMM) UMR 5247 CNRS, ENSCM, Universit\u00e9 de Montpellier, B\u00e2timent de Recherche Max Mousseron, Ecole Nationale Sup\u00e9rieure de Chimie de Montpellier , Montpellier , France."}}]}, "Language": "eng", "PublicationTypeList": {"PublicationType": [{"@UI": "D016428", "#text": "Journal Article"}, {"@UI": "D016454", "#text": "Review"}]}}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Enzyme Inhib Med Chem", "NlmUniqueID": "101150203", "ISSNLinking": "1475-6366"}, "ChemicalList": {"Chemical": [{"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D000900", "#text": "Anti-Bacterial Agents"}}, {"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D002257", "#text": "Carbonic Anhydrase Inhibitors"}}, {"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D013449", "#text": "Sulfonamides"}}, {"RegistryNumber": "EC 4.2.1.1", "NameOfSubstance": {"@UI": "D002256", "#text": "Carbonic Anhydrases"}}]}, "CitationSubset": "IM", "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"@UI": "D000900", "@MajorTopicYN": "N", "#text": "Anti-Bacterial Agents"}, "QualifierName": [{"@UI": "Q000737", "@MajorTopicYN": "N", "#text": "chemistry"}, {"@UI": "Q000494", "@MajorTopicYN": "Y", "#text": "pharmacology"}]}, {"DescriptorName": {"@UI": "D041021", "@MajorTopicYN": "N", "#text": "Brucella suis"}, "QualifierName": [{"@UI": "Q000187", "@MajorTopicYN": "Y", "#text": "drug effects"}, {"@UI": "Q000201", "@MajorTopicYN": "Y", "#text": "enzymology"}]}, {"DescriptorName": {"@UI": "D002257", "@MajorTopicYN": "N", "#text": "Carbonic Anhydrase Inhibitors"}, "QualifierName": [{"@UI": "Q000737", "@MajorTopicYN": "N", "#text": "chemistry"}, {"@UI": "Q000494", "@MajorTopicYN": "Y", "#text": "pharmacology"}]}, {"DescriptorName": {"@UI": "D002256", "@MajorTopicYN": "N", "#text": "Carbonic Anhydrases"}, "QualifierName": {"@UI": "Q000378", "@MajorTopicYN": "Y", "#text": "metabolism"}}, {"DescriptorName": {"@UI": "D004305", "@MajorTopicYN": "N", "#text": "Dose-Response Relationship, Drug"}}, {"DescriptorName": {"@UI": "D008826", "@MajorTopicYN": "N", "#text": "Microbial Sensitivity Tests"}}, {"DescriptorName": {"@UI": "D013329", "@MajorTopicYN": "N", "#text": "Structure-Activity Relationship"}}, {"DescriptorName": {"@UI": "D013449", "@MajorTopicYN": "N", "#text": "Sulfonamides"}, "QualifierName": [{"@UI": "Q000737", "@MajorTopicYN": "N", "#text": "chemistry"}, {"@UI": "Q000494", "@MajorTopicYN": "Y", "#text": "pharmacology"}]}]}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"@MajorTopicYN": "Y", "#text": "Brucella"}, {"@MajorTopicYN": "Y", "#text": "Metalloenzyme"}, {"@MajorTopicYN": "Y", "#text": "anti-infective agents"}, {"@MajorTopicYN": "Y", "#text": "carbonic anhydrase"}, {"@MajorTopicYN": "Y", "#text": "inhibitors"}]}}, "PubmedData": {"History": {"PubMedPubDate": [{"@PubStatus": "entrez", "Year": "2017", "Month": "3", "Day": "10", "Hour": "6", "Minute": "0"}, {"@PubStatus": "pubmed", "Year": "2017", "Month": "3", "Day": "10", "Hour": "6", "Minute": "0"}, {"@PubStatus": "medline", "Year": "2017", "Month": "3", "Day": "18", "Hour": "6", "Minute": "0"}]}, "PublicationStatus": "ppublish", "ArticleIdList": {"ArticleId": [{"@IdType": "pubmed", "#text": "28274160"}, {"@IdType": "doi", "#text": "10.1080/14756366.2017.1295451"}, {"@IdType": "pmc", "#text": "PMC6009918"}]}, "ReferenceList": {"Reference": [{"Citation": "Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):443-8", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "11756688"}}}, {"Citation": "J Bacteriol. 1954 Feb;67(2):233-6", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "13129218"}}}, {"Citation": "Arch Biochem Biophys. 1951 Dec;34(2):442-8", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "14904080"}}}, {"Citation": "Vet Microbiol. 2010 Jan 27;140(3-4):392-8", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "19604656"}}}, {"Citation": "J Enzyme Inhib Med Chem. 2015;30(5):857-61", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25291009"}}}, {"Citation": "J Inorg Biochem. 2012 May;110:36-9", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "22459172"}}}, {"Citation": "Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12989-94", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "14569030"}}}, {"Citation": "Int J Antimicrob Agents. 2004 Apr;23(4):405-7", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "15081093"}}}, {"Citation": "J Enzyme Inhib Med Chem. 2015 Dec;30(6):1017-20", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25676329"}}}, {"Citation": "FEMS Immunol Med Microbiol. 2005 May 1;44(2):183-9", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "15866214"}}}, {"Citation": "Bioorg Med Chem. 2015 Aug 1;23(15):4181-7", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "26145821"}}}, {"Citation": "J Enzyme Inhib Med Chem. 2015 Dec;30(6):1010-2", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25792504"}}}, {"Citation": "J Infect Dis. 2010 Jul 1;202(1):3-10", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "20497040"}}}, {"Citation": "J Inorg Biochem. 2012 Jun;111:138-45", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "22196018"}}}, {"Citation": "Lancet Infect Dis. 2006 Feb;6(2):91-9", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "16439329"}}}, {"Citation": "FEMS Microbiol Rev. 2000 Oct;24(4):335-66", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "10978542"}}}, {"Citation": "Curr Med Chem. 2015;22(18):2130-9", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25312213"}}}, {"Citation": "Appl Environ Microbiol. 2015 Jan;81(2):578-86", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25381237"}}}, {"Citation": "Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13148-53", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "12271122"}}}, {"Citation": "Infect Immun. 1999 Aug;67(8):4041-7", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "10417172"}}}, {"Citation": "Bioorg Med Chem Lett. 2010 Apr 1;20(7):2178-82", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "20211561"}}}, {"Citation": "Curr Pharm Des. 2008;14(7):622-30", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "18336307"}}}, {"Citation": "J Bacteriol. 2005 Jan;187(2):729-38", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "15629943"}}}, {"Citation": "Lancet Infect Dis. 2007 Dec;7(12):775-86", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "18045560"}}}, {"Citation": "Bioorg Med Chem. 2011 Feb 1;19(3):1172-8", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "21251841"}}}, {"Citation": "J Med Chem. 2010 Mar 11;53(5):2277-85", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "20158185"}}}, {"Citation": "Antimicrob Agents Chemother. 2007 Oct;51(10):3752-5", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "17698620"}}}, {"Citation": "Curr Pharm Des. 2010;16(29):3300-9", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "20819064"}}}, {"Citation": "Expert Opin Ther Targets. 2015;19(12):1689-704", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "26235676"}}}, {"Citation": "Curr Pharm Des. 2010;16(29):3310-6", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "20819063"}}}, {"Citation": "Mol Microbiol. 2003 Apr;48(1):77-84", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "12657046"}}}, {"Citation": "Cell Mol Life Sci. 2006 Oct;63(19-20):2229-36", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "16964579"}}}, {"Citation": "J Bacteriol. 2005 Apr;187(8):2715-26", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "15805518"}}}, {"Citation": "Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15711-6", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "12438693"}}}, {"Citation": "Bioorg Med Chem. 2014 Nov 15;22(22):6353-9", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25438758"}}}, {"Citation": "FEMS Microbiol Rev. 2010 May;34(3):379-94", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "20180858"}}}, {"Citation": "Bioorg Med Chem. 2007 Jul 1;15(13):4427-33", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "17481905"}}}]}}}, {"MedlineCitation": {"@Status": "MEDLINE", "@Owner": "NLM", "PMID": {"@Version": "1", "#text": "20211561"}, "DateCompleted": {"Year": "2010", "Month": "07", "Day": "05"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"@PubModel": "Print-Electronic", "Journal": {"ISSN": {"@IssnType": "Electronic", "#text": "1464-3405"}, "JournalIssue": {"@CitedMedium": "Internet", "Volume": "20", "Issue": "7", "PubDate": {"Year": "2010", "Month": "Apr", "Day": "01"}}, "Title": "Bioorganic & medicinal chemistry letters", "ISOAbbreviation": "Bioorg. Med. Chem. Lett."}, "ArticleTitle": "Inhibition studies of a beta-carbonic anhydrase from Brucella suis with a series of water soluble glycosyl sulfanilamides.", "Pagination": {"MedlinePgn": "2178-82"}, "ELocationID": {"@EIdType": "doi", "@ValidYN": "Y", "#text": "10.1016/j.bmcl.2010.02.042"}, "Abstract": {"AbstractText": "A beta-carbonic anhydrase (CA, EC 4.2.1.1) from the bacterial pathogen Brucella suis, bsCA 1, has been cloned, purified characterized kinetically and for inhibition with a series of water soluble glycosylated sulfanilamides. bsCA 1 has appreciable activity as catalyst for the hydration of CO(2) to bicarbonate, with a k(cat) of 6.4x10(5) s(-1) and k(cat)/K(m) of 3.9x10(7) M(-1) s(-1). All types of inhibitory activities have been detected, with K(I)s in the range of 8.9-110 nM. The best bsCA 1 inhibitor were the galactose and ribose sulfanilamides, with inhibition constants of 8.9-9.2 nM. Small structural changes in the sugar moiety led to dramatic differences of enzyme inhibitory activity for this series of compounds. One of the tested glycosylsulfonamides and acetazolamide significantly inhibited the growth of the bacteria in cell cultures.", "CopyrightInformation": "2010 Elsevier Ltd. All rights reserved."}, "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "LastName": "Vullo", "ForeName": "Daniela", "Initials": "D", "AffiliationInfo": {"Affiliation": "Universit\u00e0 degli Studi di Firenze, Polo Scientifico, Laboratorio di Chimica Bioinorganica, Rm. 188, Via della Lastruccia 3, 50019 Sesto Fiorentino (Florence), Italy."}}, {"@ValidYN": "Y", "LastName": "Nishimori", "ForeName": "Isao", "Initials": "I"}, {"@ValidYN": "Y", "LastName": "Scozzafava", "ForeName": "Andrea", "Initials": "A"}, {"@ValidYN": "Y", "LastName": "K\u00f6hler", "ForeName": "Stephan", "Initials": "S"}, {"@ValidYN": "Y", "LastName": "Winum", "ForeName": "Jean-Yves", "Initials": "JY"}, {"@ValidYN": "Y", "LastName": "Supuran", "ForeName": "Claudiu T", "Initials": "CT"}]}, "Language": "eng", "PublicationTypeList": {"PublicationType": {"@UI": "D016428", "#text": "Journal Article"}}, "ArticleDate": {"@DateType": "Electronic", "Year": "2010", "Month": "02", "Day": "21"}}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Bioorg Med Chem Lett", "NlmUniqueID": "9107377", "ISSNLinking": "0960-894X"}, "ChemicalList": {"Chemical": [{"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D002241", "#text": "Carbohydrates"}}, {"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D002257", "#text": "Carbonic Anhydrase Inhibitors"}}, {"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D013424", "#text": "Sulfanilamides"}}, {"RegistryNumber": "059QF0KO0R", "NameOfSubstance": {"@UI": "D014867", "#text": "Water"}}, {"RegistryNumber": "EC 4.2.1.-", "NameOfSubstance": {"@UI": "D024401", "#text": "Carbonic Anhydrase I"}}]}, "CitationSubset": "IM", "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"@UI": "D000595", "@MajorTopicYN": "N", "#text": "Amino Acid Sequence"}}, {"DescriptorName": {"@UI": "D041021", "@MajorTopicYN": "N", "#text": "Brucella suis"}, "QualifierName": {"@UI": "Q000201", "@MajorTopicYN": "Y", "#text": "enzymology"}}, {"DescriptorName": {"@UI": "D002241", "@MajorTopicYN": "N", "#text": "Carbohydrates"}, "QualifierName": {"@UI": "Q000737", "@MajorTopicYN": "N", "#text": "chemistry"}}, {"DescriptorName": {"@UI": "D024401", "@MajorTopicYN": "N", "#text": "Carbonic Anhydrase I"}, "QualifierName": [{"@UI": "Q000037", "@MajorTopicYN": "N", "#text": "antagonists & inhibitors"}, {"@UI": "Q000737", "@MajorTopicYN": "N", "#text": "chemistry"}, {"@UI": "Q000378", "@MajorTopicYN": "Y", "#text": "metabolism"}]}, {"DescriptorName": {"@UI": "D002257", "@MajorTopicYN": "N", "#text": "Carbonic Anhydrase Inhibitors"}, "QualifierName": [{"@UI": "Q000737", "@MajorTopicYN": "Y", "#text": "chemistry"}, {"@UI": "Q000494", "@MajorTopicYN": "Y", "#text": "pharmacology"}]}, {"DescriptorName": {"@UI": "D006801", "@MajorTopicYN": "N", "#text": "Humans"}}, {"DescriptorName": {"@UI": "D007700", "@MajorTopicYN": "N", "#text": "Kinetics"}}, {"DescriptorName": {"@UI": "D008969", "@MajorTopicYN": "N", "#text": "Molecular Sequence Data"}}, {"DescriptorName": {"@UI": "D016415", "@MajorTopicYN": "N", "#text": "Sequence Alignment"}}, {"DescriptorName": {"@UI": "D013329", "@MajorTopicYN": "N", "#text": "Structure-Activity Relationship"}}, {"DescriptorName": {"@UI": "D013424", "@MajorTopicYN": "N", "#text": "Sulfanilamides"}, "QualifierName": [{"@UI": "Q000737", "@MajorTopicYN": "Y", "#text": "chemistry"}, {"@UI": "Q000494", "@MajorTopicYN": "Y", "#text": "pharmacology"}]}, {"DescriptorName": {"@UI": "D014867", "@MajorTopicYN": "N", "#text": "Water"}, "QualifierName": {"@UI": "Q000737", "@MajorTopicYN": "N", "#text": "chemistry"}}]}}, "PubmedData": {"History": {"PubMedPubDate": [{"@PubStatus": "received", "Year": "2010", "Month": "01", "Day": "12"}, {"@PubStatus": "revised", "Year": "2010", "Month": "02", "Day": "08"}, {"@PubStatus": "accepted", "Year": "2010", "Month": "02", "Day": "08"}, {"@PubStatus": "entrez", "Year": "2010", "Month": "3", "Day": "10", "Hour": "6", "Minute": "0"}, {"@PubStatus": "pubmed", "Year": "2010", "Month": "3", "Day": "10", "Hour": "6", "Minute": "0"}, {"@PubStatus": "medline", "Year": "2010", "Month": "7", "Day": "6", "Hour": "6", "Minute": "0"}]}, "PublicationStatus": "ppublish", "ArticleIdList": {"ArticleId": [{"@IdType": "pubmed", "#text": "20211561"}, {"@IdType": "pii", "#text": "S0960-894X(10)00242-8"}, {"@IdType": "doi", "#text": "10.1016/j.bmcl.2010.02.042"}]}}}, {"MedlineCitation": {"@Status": "MEDLINE", "@Owner": "NLM", "PMID": {"@Version": "1", "#text": "20920480"}, "DateCompleted": {"Year": "2011", "Month": "01", "Day": "18"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"@PubModel": "Print-Electronic", "Journal": {"ISSN": {"@IssnType": "Electronic", "#text": "1873-2968"}, "JournalIssue": {"@CitedMedium": "Internet", "Volume": "81", "Issue": "2", "PubDate": {"Year": "2011", "Month": "Jan", "Day": "15"}}, "Title": "Biochemical pharmacology", "ISOAbbreviation": "Biochem. Pharmacol."}, "ArticleTitle": "Thioredoxin reductase 1 knockdown enhances selenazolidine cytotoxicity in human lung cancer cells via mitochondrial dysfunction.", "Pagination": {"MedlinePgn": "211-21"}, "ELocationID": {"@EIdType": "doi", "@ValidYN": "Y", "#text": "10.1016/j.bcp.2010.09.024"}, "Abstract": {"AbstractText": "Thioredoxin reductase (TR1) is a selenoprotein that is involved in cellular redox status control and deoxyribonucleotide biosynthesis. Many cancers, including lung, overexpress TR1, making it a potential cancer therapy target. Previous work has shown that TR1 knockdown enhances the sensitivity of cancer cells to anticancer treatments, as well as certain selenocompounds. However, it is unknown if TR1 knockdown produces similar effect on the sensitivity of human lung cancer cells. To further elucidate the role of TR1 in the mechanism of selenocompounds in lung cancer, a lentiviral microRNA delivery system to knockdown TR1 expression in A549 human lung adenocarcinoma cells was utilized. Cell viability was assessed after 48 hr treatment with the selenocysteine prodrug selenazolidines 2-butylselenazolidine-4(R)-carboxylic acid (BSCA) and 2-cyclohexylselenazolidine-4-(R)-carboxylic acid (ChSCA), selenocystine (SECY), methylseleninic acid (MSA), 1,4-phenylenebis(methylene)selenocyanate (p-XSC), and selenomethionine (SEM). TR1 knockdown increased the cytotoxicity of BSCA, ChSCA, and SECY but did not sensitize cells to MSA, SEM, or p-XSC. GSH and TR1 depletion together decreased cell viability, while no change was observed with GSH depletion alone. Reactive oxygen species generation was induced only in TR1 knockdown cells treated with the selenazolidines or SECY. These three compounds also decreased total intracellular glutathione levels and oxidized thioredoxin, but in a TR1 independent manner. TR1 knockdown increased selenazolidine and SECY-induced mitochondrial membrane depolarization, as well as DNA strand breaks and AIF translocation from the mitochondria. These results indicate the ability of TR1 to modulate the cytotoxic effects of BSCA, ChSCA and SECY in human lung cancer cells through mitochondrial dysfunction.", "CopyrightInformation": "2010 Elsevier Inc. All rights reserved."}, "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "LastName": "Poerschke", "ForeName": "Robyn L", "Initials": "RL", "AffiliationInfo": {"Affiliation": "Department of Pharmacology and Toxicology, University of Utah, L.S. Skaggs Pharmacy, Room 201, 30 S 2000 East, Salt Lake City, UT 84112, USA. Robyn.Poerschke@pharm.utah.edu"}}, {"@ValidYN": "Y", "LastName": "Moos", "ForeName": "Philip J", "Initials": "PJ"}]}, "Language": "eng", "GrantList": {"@CompleteYN": "Y", "Grant": [{"GrantID": "R01 CA115616", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "F31AT005041-02", "Acronym": "AT", "Agency": "NCCIH NIH HHS", "Country": "United States"}, {"GrantID": "F31 AT005041-02", "Acronym": "AT", "Agency": "NCCIH NIH HHS", "Country": "United States"}, {"GrantID": "R01 CA115616-04", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "F31 AT005041", "Acronym": "AT", "Agency": "NCCIH NIH HHS", "Country": "United States"}, {"GrantID": "CA115616", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "P30 CA042014", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}]}, "PublicationTypeList": {"PublicationType": [{"@UI": "D016428", "#text": "Journal Article"}, {"@UI": "D052061", "#text": "Research Support, N.I.H., Extramural"}]}, "ArticleDate": {"@DateType": "Electronic", "Year": "2010", "Month": "10", "Day": "12"}}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Biochem Pharmacol", "NlmUniqueID": "0101032", "ISSNLinking": "0006-2952"}, "ChemicalList": {"Chemical": [{"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D000970", "#text": "Antineoplastic Agents"}}, {"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D016566", "#text": "Organoselenium Compounds"}}, {"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D011355", "#text": "Prodrugs"}}, {"RegistryNumber": "EC 1.8.1.9", "NameOfSubstance": {"@UI": "C516124", "#text": "TXNRD1 protein, human"}}, {"RegistryNumber": "EC 1.8.1.9", "NameOfSubstance": {"@UI": "D054481", "#text": "Thioredoxin Reductase 1"}}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": {"@UI": "D020169", "#text": "Caspases"}}]}, "CitationSubset": "IM", "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"@UI": "D000230", "@MajorTopicYN": "N", "#text": "Adenocarcinoma"}, "QualifierName": {"@UI": "Q000188", "@MajorTopicYN": "Y", "#text": "drug therapy"}}, {"DescriptorName": {"@UI": "D000970", "@MajorTopicYN": "N", "#text": "Antineoplastic Agents"}, "QualifierName": [{"@UI": "Q000737", "@MajorTopicYN": "N", "#text": "chemistry"}, {"@UI": "Q000494", "@MajorTopicYN": "Y", "#text": "pharmacology"}]}, {"DescriptorName": {"@UI": "D020169", "@MajorTopicYN": "N", "#text": "Caspases"}, "QualifierName": [{"@UI": "Q000235", "@MajorTopicYN": "N", "#text": "genetics"}, {"@UI": "Q000378", "@MajorTopicYN": "N", "#text": "metabolism"}]}, {"DescriptorName": {"@UI": "D016923", "@MajorTopicYN": "N", "#text": "Cell Death"}}, {"DescriptorName": {"@UI": "D045744", "@MajorTopicYN": "N", "#text": "Cell Line, Tumor"}}, {"DescriptorName": {"@UI": "D053938", "@MajorTopicYN": "N", "#text": "DNA Fragmentation"}}, {"DescriptorName": {"@UI": "D015972", "@MajorTopicYN": "N", "#text": "Gene Expression Regulation, Neoplastic"}}, {"DescriptorName": {"@UI": "D020868", "@MajorTopicYN": "N", "#text": "Gene Silencing"}}, {"DescriptorName": {"@UI": "D006801", "@MajorTopicYN": "N", "#text": "Humans"}}, {"DescriptorName": {"@UI": "D008175", "@MajorTopicYN": "N", "#text": "Lung Neoplasms"}, "QualifierName": {"@UI": "Q000188", "@MajorTopicYN": "Y", "#text": "drug therapy"}}, {"DescriptorName": {"@UI": "D008928", "@MajorTopicYN": "N", "#text": "Mitochondria"}, "QualifierName": {"@UI": "Q000187", "@MajorTopicYN": "N", "#text": "drug effects"}}, {"DescriptorName": {"@UI": "D016566", "@MajorTopicYN": "N", "#text": "Organoselenium Compounds"}, "QualifierName": {"@UI": "Q000494", "@MajorTopicYN": "Y", "#text": "pharmacology"}}, {"DescriptorName": {"@UI": "D010084", "@MajorTopicYN": "N", "#text": "Oxidation-Reduction"}}, {"DescriptorName": {"@UI": "D011355", "@MajorTopicYN": "N", "#text": "Prodrugs"}, "QualifierName": [{"@UI": "Q000737", "@MajorTopicYN": "N", "#text": "chemistry"}, {"@UI": "Q000494", "@MajorTopicYN": "Y", "#text": "pharmacology"}]}, {"DescriptorName": {"@UI": "D054481", "@MajorTopicYN": "N", "#text": "Thioredoxin Reductase 1"}, "QualifierName": [{"@UI": "Q000235", "@MajorTopicYN": "N", "#text": "genetics"}, {"@UI": "Q000378", "@MajorTopicYN": "Y", "#text": "metabolism"}]}]}}, "PubmedData": {"History": {"PubMedPubDate": [{"@PubStatus": "received", "Year": "2010", "Month": "07", "Day": "16"}, {"@PubStatus": "revised", "Year": "2010", "Month": "09", "Day": "24"}, {"@PubStatus": "accepted", "Year": "2010", "Month": "09", "Day": "27"}, {"@PubStatus": "entrez", "Year": "2010", "Month": "10", "Day": "6", "Hour": "6", "Minute": "0"}, {"@PubStatus": "pubmed", "Year": "2010", "Month": "10", "Day": "6", "Hour": "6", "Minute": "0"}, {"@PubStatus": "medline", "Year": "2011", "Month": "1", "Day": "19", "Hour": "6", "Minute": "0"}]}, "PublicationStatus": "ppublish", "ArticleIdList": {"ArticleId": [{"@IdType": "pubmed", "#text": "20920480"}, {"@IdType": "pii", "#text": "S0006-2952(10)00722-7"}, {"@IdType": "doi", "#text": "10.1016/j.bcp.2010.09.024"}, {"@IdType": "pmc", "#text": "PMC3005891"}, {"@IdType": "mid", "#text": "NIHMS242554"}]}, "ReferenceList": {"Reference": [{"Citation": "Cancer Res. 2008 Oct 1;68(19):7975-84", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "18829555"}}}, {"Citation": "Toxicol In Vitro. 2008 Oct;22(7):1761-7", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "18768157"}}}, {"Citation": "Int J Biochem Cell Biol. 2009 Mar;41(3):666-76", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "18718551"}}}, {"Citation": "Clin Cancer Res. 2009 May 15;15(10):3423-32", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "19417020"}}}, {"Citation": "Histopathology. 2009 Sep;55(3):313-20", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "19723146"}}}, {"Citation": "Free Radic Biol Med. 2009 Dec 1;47(11):1661-71", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "19766715"}}}, {"Citation": "Toxicol Appl Pharmacol. 2009 Dec 15;241(3):348-55", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "19782697"}}}, {"Citation": "J Clin Oncol. 2009 Dec 10;27(35):6052-69", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "19901123"}}}, {"Citation": "PLoS One. 2010;5(1):e8786", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "20098717"}}}, {"Citation": "Invest New Drugs. 2010 Jun;28(3):205-15", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "19271154"}}}, {"Citation": "Clin Cancer Res. 2010 Jul 15;16(14):3743-53", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "20534738"}}}, {"Citation": "Clin Cancer Res. 2001 Jun;7(6):1750-7", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "11410516"}}}, {"Citation": "Clin Cancer Res. 2001 Oct;7(10):3087-91", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "11595699"}}}, {"Citation": "Bioorg Med Chem Lett. 2001 Nov 19;11(22):2911-5", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "11677125"}}}, {"Citation": "Free Radic Biol Med. 2001 Nov 15;31(10):1170-8", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "11705695"}}}, {"Citation": "Oncogene. 2002 Jan 3;21(1):65-77", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "11791177"}}}, {"Citation": "Int J Oncol. 2002 Mar;20(3):557-61", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "11836568"}}}, {"Citation": "Methods Enzymol. 2002;347:317-26", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "11898422"}}}, {"Citation": "J Biol Chem. 2003 Jan 10;278(2):745-50", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "12424231"}}}, {"Citation": "Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1672-6", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "8127864"}}}, {"Citation": "JAMA. 1996 Dec 25;276(24):1957-63", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "8971064"}}}, {"Citation": "Science. 1997 Jan 3;275(5296):90-4", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "8974401"}}}, {"Citation": "Carcinogenesis. 1997 Sep;18(9):1855-7", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "9328187"}}}, {"Citation": "EMBO J. 1998 May 1;17(9):2596-606", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "9564042"}}}, {"Citation": "Nature. 1999 Feb 4;397(6718):441-6", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "9989411"}}}, {"Citation": "J Biol Chem. 1999 Aug 27;274(35):24522-30", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "10455115"}}}, {"Citation": "Free Radic Biol Med. 1999 Sep;27(5-6):504-14", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "10490269"}}}, {"Citation": "Biochem Pharmacol. 2005 Jun 15;69(12):1765-72", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "15935149"}}}, {"Citation": "J Biochem Mol Toxicol. 2005;19(6):396-405", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "16421895"}}}, {"Citation": "J Biol Chem. 2006 May 12;281(19):13005-8", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "16565519"}}}, {"Citation": "Carcinogenesis. 2006 Jul;27(7):1369-76", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "16399772"}}}, {"Citation": "Chem Biol Interact. 2006 Jul 25;162(1):31-42", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "16765927"}}}, {"Citation": "BJU Int. 2003 May;91(7):608-12", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "12699469"}}}, {"Citation": "Chem Biol Interact. 2007 Jul 20;168(3):211-20", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "17543294"}}}, {"Citation": "PLoS Med. 2006 Oct;3(10):e420", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "17020408"}}}, {"Citation": "J Med Chem. 2003 Jul 17;46(15):3308-13", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "12852761"}}}, {"Citation": "Biochem Pharmacol. 2003 Dec 15;66(12):2301-11", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "14637188"}}}, {"Citation": "Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1248-52", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "14652289"}}}, {"Citation": "Biochem Pharmacol. 2004 Feb 1;67(3):513-22", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "15037203"}}}, {"Citation": "Life Sci. 2004 Jun 11;75(4):447-59", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "15147831"}}}, {"Citation": "Oncogene. 2004 Aug 19;23(37):6282-91", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "15286713"}}}, {"Citation": "Cancer Res. 2004 Sep 15;64(18):6716-24", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "15374989"}}}, {"Citation": "PLoS One. 2007;2(10):e1112", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "17971875"}}}, {"Citation": "Cell Biol Toxicol. 2008 Apr;24(2):123-41", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "17610029"}}}, {"Citation": "Biochem Biophys Res Commun. 2008 Apr 11;368(3):832-6", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "18267104"}}}, {"Citation": "Nutr Cancer. 2008;60(2):155-63", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "18444146"}}}, {"Citation": "Carcinogenesis. 2008 May;29(5):1005-12", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "18310093"}}}, {"Citation": "Int J Cancer. 2008 Oct 15;123(8):1770-8", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "18661523"}}}, {"Citation": "JAMA. 2009 Jan 7;301(1):39-51", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "19066370"}}}]}}}]}}